Overview

Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept

Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Effects of serotonin 2A/1A receptor stimulation by psilocybin on mood and emotion processing in major depressive disorder: a randomized double-blind placebo-controlled study
Phase:
Phase 2
Details
Lead Sponsor:
Franz Xaver Vollenweider
University of Zurich
Collaborator:
Schweizerischer Nationalfonds
Treatments:
Psilocybin